This is an old revision of this page, as edited by Beetstra (talk | contribs) at 07:21, 18 February 2012 (Saving copy of the {{drugbox}} taken from revid 476407199 of page Lacosamide for the Chem/Drugbox validation project (updated: 'CAS_number').). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 07:21, 18 February 2012 by Beetstra (talk | contribs) (Saving copy of the {{drugbox}} taken from revid 476407199 of page Lacosamide for the Chem/Drugbox validation project (updated: 'CAS_number').)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)This page contains a copy of the infobox ({{drugbox}}) taken from revid 476407199 of page Lacosamide with values updated to verified values. |
Clinical data | |
---|---|
Trade names | Vimpat |
Other names | (2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide |
AHFS/Drugs.com | Monograph |
MedlinePlus | a609028 |
Routes of administration | Oral, intravenous |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | High |
Elimination half-life | 13 hours |
Identifiers | |
IUPAC name
| |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
Chemical and physical data | |
Formula | C13H18N2O3 |
Molar mass | 250.294 g/mol g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |